KONINKLIJKE PHILIPS NVR- NY (PHG) Stock Fundamental Analysis
NYSE:PHG - New York Stock Exchange, Inc. - US5004723038 - Currency: USD
Taking everything into account, PHG scores 4 out of 10 in our fundamental rating. PHG was compared to 191 industry peers in the Health Care Equipment & Supplies industry. PHG has a bad profitability rating. Also its financial health evaluation is rather negative. PHG has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year PHG was profitable.
In the past year PHG had a positive cash flow from operations.
In multiple years PHG reported negative net income over the last 5 years.
Of the past 5 years PHG 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of PHG (-2.42%) is better than 69.11% of its industry peers.
Looking at the Return On Equity, with a value of -5.85%, PHG is in the better half of the industry, outperforming 70.16% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.42% | ||
| ROE | -5.85% | ||
| ROIC | N/A |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHG's Operating Margin has declined in the last couple of years.
The Gross Margin of PHG (43.13%) is worse than 64.92% of its industry peers.
In the last couple of years the Gross Margin of PHG has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for PHG so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.13% |
OM growth 3Y-2.25%
OM growth 5Y-8.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
PHG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PHG has less shares outstanding
Compared to 5 years ago, PHG has more shares outstanding
Compared to 1 year ago, PHG has a worse debt to assets ratio.
2.2 Solvency
PHG has an Altman-Z score of 1.60. This is a bad value and indicates that PHG is not financially healthy and even has some risk of bankruptcy.
With a decent Altman-Z score value of 1.60, PHG is doing good in the industry, outperforming 60.21% of the companies in the same industry.
PHG has a debt to FCF ratio of 8.68. This is a slightly negative value and a sign of low solvency as PHG would need 8.68 years to pay back of all of its debts.
PHG has a better Debt to FCF ratio (8.68) than 75.92% of its industry peers.
PHG has a Debt/Equity ratio of 0.59. This is a neutral value indicating PHG is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.59, PHG is not doing good in the industry: 64.40% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 8.68 | ||
| Altman-Z | 1.6 |
ROIC/WACCN/A
WACC6.3%
2.3 Liquidity
A Current Ratio of 1.23 indicates that PHG should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.23, PHG is doing worse than 78.53% of the companies in the same industry.
PHG has a Quick Ratio of 1.23. This is a bad value and indicates that PHG is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.84, PHG is not doing good in the industry: 82.72% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.72% over the past year.
The Earnings Per Share has been decreasing by -7.17% on average over the past years.
Looking at the last year, PHG shows a decrease in Revenue. The Revenue has decreased by -0.82% in the last year.
Measured over the past years, PHG shows a small growth in Revenue. The Revenue has been growing by 1.00% on average per year.
EPS 1Y (TTM)11.72%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%24.39%
Revenue 1Y (TTM)-0.82%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.36%
3.2 Future
The Earnings Per Share is expected to grow by 12.99% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.55% on average over the next years.
EPS Next Y9.94%
EPS Next 2Y11.54%
EPS Next 3Y12.13%
EPS Next 5Y12.99%
Revenue Next Year3.9%
Revenue Next 2Y4.18%
Revenue Next 3Y4.38%
Revenue Next 5Y3.55%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 15.79, PHG is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of PHG indicates a rather cheap valuation: PHG is cheaper than 85.86% of the companies listed in the same industry.
PHG is valuated rather cheaply when we compare the Price/Earnings ratio to 28.92, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 14.40, PHG is valued correctly.
PHG's Price/Forward Earnings ratio is rather cheap when compared to the industry. PHG is cheaper than 86.39% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.65. PHG is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.79 | ||
| Fwd PE | 14.4 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PHG is valued a bit cheaper than the industry average as 77.49% of the companies are valued more expensively.
PHG's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PHG is cheaper than 84.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.43 | ||
| EV/EBITDA | 18.58 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PHG's earnings are expected to grow with 12.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.59
PEG (5Y)N/A
EPS Next 2Y11.54%
EPS Next 3Y12.13%
5. Dividend
5.1 Amount
PHG has a Yearly Dividend Yield of 4.26%, which is a nice return.
Compared to an average industry Dividend Yield of 1.94, PHG pays a better dividend. On top of this PHG pays more dividend than 98.95% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.51, PHG pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.26% |
5.2 History
The dividend of PHG decreases each year by -70.49%.
PHG has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-70.49%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of PHG are negative and hence is the payout ratio. PHG will probably not be able to sustain this dividend level.
DP-0.14%
EPS Next 2Y11.54%
EPS Next 3Y12.13%
NYSE:PHG (4/25/2025, 11:05:58 AM)
24.955
+0.23 (+0.95%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners48.26%
Inst Owner Change0.82%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap23.46B
Analysts73.08
Price Target31.53 (26.35%)
Short Float %0.24%
Short Ratio1.82
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.26% |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP-0.14%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-14.27%
Min EPS beat(2)-16.56%
Max EPS beat(2)-11.97%
EPS beat(4)0
Avg EPS beat(4)-12.16%
Min EPS beat(4)-16.56%
Max EPS beat(4)-6.96%
EPS beat(8)2
Avg EPS beat(8)0.79%
EPS beat(12)3
Avg EPS beat(12)3.3%
EPS beat(16)5
Avg EPS beat(16)1.18%
Revenue beat(2)0
Avg Revenue beat(2)-4.13%
Min Revenue beat(2)-5.22%
Max Revenue beat(2)-3.04%
Revenue beat(4)0
Avg Revenue beat(4)-3.42%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-2.46%
Revenue beat(8)1
Avg Revenue beat(8)-2.64%
Revenue beat(12)2
Avg Revenue beat(12)-1.69%
Revenue beat(16)2
Avg Revenue beat(16)-2.44%
PT rev (1m)4.72%
PT rev (3m)4.82%
EPS NQ rev (1m)-12.16%
EPS NQ rev (3m)-2.2%
EPS NY rev (1m)-2.3%
EPS NY rev (3m)-8.98%
Revenue NQ rev (1m)-2.06%
Revenue NQ rev (3m)-3.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.79 | ||
| Fwd PE | 14.4 | ||
| P/S | 1.14 | ||
| P/FCF | 23.43 | ||
| P/OCF | 13.25 | ||
| P/B | 1.72 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.58 |
EPS(TTM)1.58
EY6.33%
EPS(NY)1.73
Fwd EY6.94%
FCF(TTM)1.07
FCFY4.27%
OCF(TTM)1.88
OCFY7.55%
SpS21.81
BVpS14.53
TBVpS-1.64
PEG (NY)1.59
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.42% | ||
| ROE | -5.85% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.13% | ||
| FCFM | 4.88% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.25%
OM growth 5Y-8.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score6
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 8.68 | ||
| Debt/EBITDA | 5.15 | ||
| Cap/Depr | 48.63% | ||
| Cap/Sales | 3.75% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 112.67% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | 1.6 |
F-Score6
WACC6.3%
ROIC/WACCN/A
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.72%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%24.39%
EPS Next Y9.94%
EPS Next 2Y11.54%
EPS Next 3Y12.13%
EPS Next 5Y12.99%
Revenue 1Y (TTM)-0.82%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.36%
Revenue Next Year3.9%
Revenue Next 2Y4.18%
Revenue Next 3Y4.38%
Revenue Next 5Y3.55%
EBIT growth 1Y91.51%
EBIT growth 3Y-0.63%
EBIT growth 5Y-7.54%
EBIT Next Year57.53%
EBIT Next 3Y22.84%
EBIT Next 5YN/A
FCF growth 1Y-45.51%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y-31.12%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%